Ads
related to: alternative therapy for multiple sclerosis disease- Starting Treatment
Download These Resources To
Help Your Patients Get Started.
- Patient Support Services
See Information On Our
Patient Support Program.
- Safety And Vaccine Data
See Data On Long-Term
Safety And Tolerability.
- Discover Efficacy Data
Explore Clinical Trial And
Efficacy Data.
- Mechanism Of Action
View This Informational Video
About This Treatment's MOA.
- Dosing & Administration
Discover Dosing Information
For This Treatment.
- Starting Treatment
Search results
Results From The WOW.Com Content Network
In March 2017, ocrelizumab was approved in the United States for the treatment of primary progressive multiple sclerosis in adults. [22] [42] It is also used for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. [42]
Multiple sclerosis is an autoimmune disease, ... Alternative treatments are pursued ... option for patients with multiple sclerosis. Physical therapy including ...
Alemtuzumab, sold under the brand names Campath and Lemtrada among others, is a medication used to treat chronic lymphocytic leukemia and multiple sclerosis. [8] In chronic lymphocytic leukemia, it has been used as both a first line and second line treatment. [8] It is given by injection into a vein. [8]
In the United states, natalizumab is indicated for the treatment of multiple sclerosis and Crohn's disease. [1] [9] It is indicated to treat clinically isolated syndrome – a single, first occurrence of multiple sclerosis symptoms; relapsing-remitting disease – a type of multiple sclerosis that occurs when people have episodes of new neurological symptoms followed by periods of stability ...
The Swank Diet is a diet that is low in saturated fat, which was proposed in 1949 by Roy Laver Swank, MD, PhD (1909–2008), academic neurologist at the University of Oregon, for the treatment of multiple sclerosis. [1] The claims made for the diet are unsubstantiated. [1] [2]
Glatiramer acetate, sold under the brand name Copaxone among others, is an immunomodulator medication used to treat multiple sclerosis. [1] [2] Glatiramer acetate is approved in the United States to reduce the frequency of relapses, but not for reducing the progression of disability.
Ads
related to: alternative therapy for multiple sclerosis disease